Home Biosimilar Antibodies Neuronal Signaling Beta Amyloid antibody Aducanumab (Anti-Amyloid Beta) For research use only.
Not for use in humans.

Aducanumab (Anti-Amyloid Beta)

Synonyms: BIIB037

Aducanumab (Anti-Amyloid Beta) is a selective human monoclonal antibody targeting aggregated forms of amyloid beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research.MW :145.5 KD.

Aducanumab (Anti-Amyloid Beta)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 10.1mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Beta Amyloid Inhibitors

Biological Activity

Description Aducanumab (Anti-Amyloid Beta) is a selective human monoclonal antibody targeting aggregated forms of amyloid beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research.MW :145.5 KD.

Product Details

CAS No. 1384260-65-4
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Aducanumab (Anti-Amyloid Beta) | Aducanumab (Anti-Amyloid Beta) supplier | purchase Aducanumab (Anti-Amyloid Beta) | Aducanumab (Anti-Amyloid Beta) cost | Aducanumab (Anti-Amyloid Beta) manufacturer | order Aducanumab (Anti-Amyloid Beta) | Aducanumab (Anti-Amyloid Beta) distributor